Cambridge Investment Research Advisors’s AdvanSix ASIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-10,606
Closed -$206K – 3825
2025
Q3
$206K Buy
+10,606
New +$223K ﹤0.01% 3462
2024
Q3
– Sell
-8,863
Closed -$203K – 3416
2024
Q2
$203K Buy
8,863
+1,199
+16% +$29.9K ﹤0.01% 3020
2024
Q1
$219K Buy
7,664
+205
+3% +$5.48K ﹤0.01% 2955
2023
Q4
$223K Sell
7,459
-936
-11% -$26K ﹤0.01% 2822
2023
Q3
$261K Sell
8,395
-6
-0.1% -$208 ﹤0.01% 2601
2023
Q2
$294K Buy
8,401
+227
+3% +$8.23K ﹤0.01% 2537
2023
Q1
$313K Sell
8,174
-707
-8% -$28.3K ﹤0.01% 2452
2022
Q4
$338K Buy
8,881
+75
+0.9% +$2.81K ﹤0.01% 2334
2022
Q3
$283K Buy
8,806
+478
+6% +$17.2K ﹤0.01% 2407
2022
Q2
$278K Buy
8,328
+34
+0.4% +$1.52K ﹤0.01% 2446
2022
Q1
$424K Sell
8,294
-620
-7% -$27.6K ﹤0.01% 2234
2021
Q4
$421K Buy
8,914
+547
+7% +$25.2K ﹤0.01% 2253
2021
Q3
$333K Buy
8,367
+954
+13% +$32.8K ﹤0.01% 2379
2021
Q2
$221K Sell
7,413
-987
-12% -$29.6K ﹤0.01% 2734
2021
Q1
$225K Buy
+8,400
New +$214K ﹤0.01% 2514

Other funds holding ASIX

Cambridge Investment Research Advisors's ASIX Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of AdvanSix (ASIX) in Q4 2025, closing a stake of 10,606 shares — an estimated $206K sold.

Cambridge Investment Research Advisors first reported a position in ASIX in Q1 2021 and held it in 15 quarters. The position peaked at $424K in Q1 2022. 278 funds tracked by Wall St. Rank hold ASIX as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining AdvanSix position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,606 AdvanSix shares in Q4 2025, an estimated $206K.
  • Cambridge Investment Research Advisors first reported a position in AdvanSix in Q1 2021 and held it in 15 quarters.
  • Cambridge Investment Research Advisors's AdvanSix position peaked at $424K in Q1 2022.
  • 278 funds tracked by Wall St. Rank held AdvanSix as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.